{
  "symbol": "GE",
  "year": 2024,
  "Period": "Q1",
  "report_type": "Q10",
  "metrics": {
    "mdna_sentiment": -0.3182,
    "outlook_sentiment": 0.3018,
    "forward_ratio": 1.0,
    "hedge_ratio": 0.064
  },
  "top_positive": [
    {
      "sent": "Period Total number of shares purchased Average price paid per share Total number of shares purchased as part of our share repurchase authorizations Approximate dollar value of shares that may yet be purchased under our $15 billion  share repurchase authorization (Shares in thousands) 2024 July 1,748 $ 166.33 1,748 August 6,153 165.77 6,153 September \u2014 \u2014 \u2014 Total 7,901 $ 165.90 7,901 $ 11,744 *Non-GAAP Financial Measure 2024 3Q FORM 10-Q 15 STATEMENT OF EARNINGS (LOSS) (UNAUDITED) Three Months Ended September 30 Nine months ended September 30 (In millions, per-share amounts in dollars) 2024 2023 2024 2023 Sales of equipment $ 2,448 $ 2,298 $ 7,044 $ 6,804 Sales of services 6,495 6,162 18,198 16,608 Insurance revenues (Note 12) 899 842 2,649 2,480 Total revenues 9,842 9,302 27,890 25,893 Cost of equipment sold 2,625 2,443 7,391 7,187 Cost of services sold 3,601 3,549 10,155 9,496 Selling, general and administrative expenses 1,330 1,001 3,280 2,846 Separation costs 74 147 408 474 Research and development 331 247 901 715 Interest and other financial charges 251 270 762 767 Insurance losses, annuity benefits and other costs (Note 12) 714 710 2,008 2,129 Goodwill impairments (Note 7) 251 \u2014 251 \u2014 Non-operating benefit cost (income) ( 207 ) ( 244 ) ( 628 ) ( 731 ) Total costs and expenses 8,970 8,124 24,529 22,883 Other income (loss) (Note 18) 1,021 ( 845 ) 1,965 5,755 Earnings (loss) from continuing operations before income taxes 1,893 333 5,327 8,765 Benefit (provision) for income taxes (Note 15) ( 198 ) ( 26 ) ( 567 ) ( 493 ) Earnings (loss) from continuing operations 1,695 307 4,760 8,272 Earnings (loss) from discontinued operations, net of taxes (Note 2) 147 31 ( 85 ) ( 415 ) Net earnings (loss) 1,842 338 4,676 7,857 Less net earnings (loss) attributable to noncontrolling interests ( 10 ) ( 14 ) 18 ( 37 ) Net earnings (loss) attributable to the Company 1,852 352 4,657 7,894 Preferred stock dividends \u2014 ( 91 ) \u2014 ( 295 ) Net earnings (loss) attributable to common shareholders $ 1,852 $ 261 $ 4,657 $ 7,599 Amounts attributable to common shareholders Earnings (loss) from continuing operations $ 1,695 $ 307 $ 4,760 $ 8,272 Less net earnings (loss) attributable to noncontrolling interests, continuing operations ( 10 ) 1 ( 5 ) 7 Earnings (loss) from continuing operations attributable to the Company 1,705 306 4,766 8,264 Preferred stock dividends \u2014 ( 91 ) \u2014 ( 295 ) Earnings (loss) from continuing operations attributable to common shareholders 1,705 215 4,766 7,970 Earnings (loss) from discontinued operations attributable to common shareholders 147 46 ( 108 ) ( 371 ) Net earnings (loss) attributable to common shareholders $ 1,852 $ 261 $ 4,657 $ 7,599 Earnings (loss) per share from continuing operations (Note 17) Diluted earnings (loss) per share $ 1.56 $ 0.20 $ 4.34 $ 7.25 Basic earnings (loss) per share $ 1.57 $ 0.20 $ 4.38 $ 7.32 Net earnings (loss) per share (Note 17) Diluted earnings (loss) per share $ 1.70 $ 0.24 $ 4.24 $ 6.92 Basic earnings (loss) per share $ 1.71 $ 0.24 $ 4.28 $ 6.98 2024 3Q FORM 10-Q 16 STATEMENT OF FINANCIAL POSITION (UNAUDITED) (In millions, except share amounts) September 30, 2024 December 31, 2023 Cash, cash equivalents and restricted cash $ 13,724 $ 15,204 Investment securities (Note 3) 2,232 5,706 Current receivables (Note 4) 8,936 8,703 Inventories, including deferred inventory costs (Note 5) 9,718 8,284 Current contract assets (Note 8) 2,884 2,875 All other current assets (Note 9) 1,156 1,244 Assets of businesses held for sale (Note 2) \u2014 541 Current assets 38,649 42,556 Investment securities (Note 3) 39,514 38,000 Property, plant and equipment \u2013 net (Note 6) 7,254 7,246 Goodwill (Note 7) 8,754 8,948 Other intangible assets \u2013 net (Note 7) 4,371 4,642 Contract and other deferred assets (Note 8) 4,823 4,785 All other assets (Note 9) 13,836 11,695 Deferred income taxes (Note 15) 7,491 7,502 Assets of discontinued operations (Note 2) 2,006 47,927 Total assets $ 126,698 $ 173,300 Short-term borrowings (Note 10) $ 1,681 $ 1,108 Accounts payable (Note 11) 7,829 7,516 Progress collections (Note 8) 6,477 6,177 Contract liabilities and deferred income (Note 8) 9,047 8,322 Sales discounts and allowances (Note 14) 4,073 3,741 All other current liabilities (Note 14) 4,986 4,860 Liabilities of businesses held for sale (Note 2) \u2014 378 Current liabilities 34,093 32,103 Deferred income (Note 8) 972 975 Long-term borrowings (Note 10) 18,240 19,417 Insurance liabilities and annuity benefits (Note 12) 39,147 39,624 Non-current compensation and benefits (Note 14) 7,169 7,656 All other liabilities (Note 14) 6,647 5,708 Liabilities of discontinued operations (Note 2) 1,328 39,213 Total liabilities 107,595 144,695 Common stock ( 1,082,294,004 and 1,088,415,995 shares outstanding at September 30, 2024 and December 31, 2023, respectively)  (Note 16) 15 15 Accumulated other comprehensive income (loss) \u2013 net attributable to the Company (Note 16) ( 4,375 ) ( 6,150 ) Other cap\neve the retained cost in Adjusted earnings* and the Adjusted effective income tax rate* provides management and investors a useful measure to evaluate the performance of the total company and increases period-to-period comparability.",
      "score": 0.9969
    },
    {
      "sent": "Period Total number of shares purchased Average price paid per share Total number of shares purchased as part of our share repurchase authorizations Approximate dollar value of shares that may yet be purchased under our $15 billion  share repurchase authorization (Shares in thousands) 2024 July 1,748 $ 166.33 1,748 August 6,153 165.77 6,153 September \u2014 \u2014 \u2014 Total 7,901 $ 165.90 7,901 $ 11,744 *Non-GAAP Financial Measure 2024 3Q FORM 10-Q 15 STATEMENT OF EARNINGS (LOSS) (UNAUDITED) Three Months Ended September 30 Nine months ended September 30 (In millions, per-share amounts in dollars) 2024 2023 2024 2023 Sales of equipment $ 2,448 $ 2,298 $ 7,044 $ 6,804 Sales of services 6,495 6,162 18,198 16,608 Insurance revenues (Note 12) 899 842 2,649 2,480 Total revenues 9,842 9,302 27,890 25,893 Cost of equipment sold 2,625 2,443 7,391 7,187 Cost of services sold 3,601 3,549 10,155 9,496 Selling, general and administrative expenses 1,330 1,001 3,280 2,846 Separation costs 74 147 408 474 Research and development 331 247 901 715 Interest and other financial charges 251 270 762 767 Insurance losses, annuity benefits and other costs (Note 12) 714 710 2,008 2,129 Goodwill impairments (Note 7) 251 \u2014 251 \u2014 Non-operating benefit cost (income) ( 207 ) ( 244 ) ( 628 ) ( 731 ) Total costs and expenses 8,970 8,124 24,529 22,883 Other income (loss) (Note 18) 1,021 ( 845 ) 1,965 5,755 Earnings (loss) from continuing operations before income taxes 1,893 333 5,327 8,765 Benefit (provision) for income taxes (Note 15) ( 198 ) ( 26 ) ( 567 ) ( 493 ) Earnings (loss) from continuing operations 1,695 307 4,760 8,272 Earnings (loss) from discontinued operations, net of taxes (Note 2) 147 31 ( 85 ) ( 415 ) Net earnings (loss) 1,842 338 4,676 7,857 Less net earnings (loss) attributable to noncontrolling interests ( 10 ) ( 14 ) 18 ( 37 ) Net earnings (loss) attributable to the Company 1,852 352 4,657 7,894 Preferred stock dividends \u2014 ( 91 ) \u2014 ( 295 ) Net earnings (loss) attributable to common shareholders $ 1,852 $ 261 $ 4,657 $ 7,599 Amounts attributable to common shareholders Earnings (loss) from continuing operations $ 1,695 $ 307 $ 4,760 $ 8,272 Less net earnings (loss) attributable to noncontrolling interests, continuing operations ( 10 ) 1 ( 5 ) 7 Earnings (loss) from continuing operations attributable to the Company 1,705 306 4,766 8,264 Preferred stock dividends \u2014 ( 91 ) \u2014 ( 295 ) Earnings (loss) from continuing operations attributable to common shareholders 1,705 215 4,766 7,970 Earnings (loss) from discontinued operations attributable to common shareholders 147 46 ( 108 ) ( 371 ) Net earnings (loss) attributable to common shareholders $ 1,852 $ 261 $ 4,657 $ 7,599 Earnings (loss) per share from continuing operations (Note 17) Diluted earnings (loss) per share $ 1.56 $ 0.20 $ 4.34 $ 7.25 Basic earnings (loss) per share $ 1.57 $ 0.20 $ 4.38 $ 7.32 Net earnings (loss) per share (Note 17) Diluted earnings (loss) per share $ 1.70 $ 0.24 $ 4.24 $ 6.92 Basic earnings (loss) per share $ 1.71 $ 0.24 $ 4.28 $ 6.98 2024 3Q FORM 10-Q 16 STATEMENT OF FINANCIAL POSITION (UNAUDITED) (In millions, except share amounts) September 30, 2024 December 31, 2023 Cash, cash equivalents and restricted cash $ 13,724 $ 15,204 Investment securities (Note 3) 2,232 5,706 Current receivables (Note 4) 8,936 8,703 Inventories, including deferred inventory costs (Note 5) 9,718 8,284 Current contract assets (Note 8) 2,884 2,875 All other current assets (Note 9) 1,156 1,244 Assets of businesses held for sale (Note 2) \u2014 541 Current assets 38,649 42,556 Investment securities (Note 3) 39,514 38,000 Property, plant and equipment \u2013 net (Note 6) 7,254 7,246 Goodwill (Note 7) 8,754 8,948 Other intangible assets \u2013 net (Note 7) 4,371 4,642 Contract and other deferred assets (Note 8) 4,823 4,785 All other assets (Note 9) 13,836 11,695 Deferred income taxes (Note 15) 7,491 7,502 Assets of discontinued operations (Note 2) 2,006 47,927 Total assets $ 126,698 $ 173,300 Short-term borrowings (Note 10) $ 1,681 $ 1,108 Accounts payable (Note 11) 7,829 7,516 Progress collections (Note 8) 6,477 6,177 Contract liabilities and deferred income (Note 8) 9,047 8,322 Sales discounts and allowances (Note 14) 4,073 3,741 All other current liabilities (Note 14) 4,986 4,860 Liabilities of businesses held for sale (Note 2) \u2014 378 Current liabilities 34,093 32,103 Deferred income (Note 8) 972 975 Long-term borrowings (Note 10) 18,240 19,417 Insurance liabilities and annuity benefits (Note 12) 39,147 39,624 Non-current compensation and benefits (Note 14) 7,169 7,656 All other liabilities (Note 14) 6,647 5,708 Liabilities of discontinued operations (Note 2) 1,328 39,213 Total liabilities 107,595 144,695 Common stock ( 1,082,294,004 and 1,088,415,995 shares outstanding at September 30, 2024 and December 31, 2023, respectively)  (Note 16) 15 15 Accumulated other comprehensive income (loss) \u2013 net attributable to the Company (Note 16) ( 4,375 ) ( 6,150 ) Other capital 24,406 26,962 Retained earnings 78,889 86,553 Less common stock held in treasury ( 80,061 ) ( 79,976 ) Total shareholders\u2019 equity 18,874 27,403 Noncontrolling interests 229 1,202 Total equity 19,102 28,605 Total liabilities and equity $ 126,698 $ 173,300 2024 3Q FORM 10-Q 17 STATEMENT OF CASH FLOWS (UNAUDITED) Nine months ended September 30 (In millions) 2024 2023 Net earnings (loss) $ 4,676 $ 7,857 (Earnings) loss from discontinued operations activities 85 415 Adjustments to reconcile net earnings (loss) to cash from (used for) operating activities: Depreciation and amortization of property, plant and equipment 625 592 Amortization of intangible assets (Note 7) 261 278 Goodwill impairments (Note 7) 251 \u2014 (Gains) losses on equity securities (Note 18) ( 723 ) ( 5,185 ) Principal pension plans cost (Note 13) ( 491 ) ( 570 ) Principal pension plans employer contributions ( 142 ) ( 134 ) Other postretirement benefit plans (net) ( 221 ) ( 273 ) Provision (benefit) for income taxes (Note 15) 567 493 Cash recovered (paid) during the year for income taxes ( 42 ) ( 703 )\n24 and December 31, 2023, respectively.",
      "score": 0.9969
    },
    {
      "sent": "Period Total number of shares purchased Average price paid per share Total number of shares purchased as part of our share repurchase authorizations Approximate dollar value of shares that may yet be purchased under our $15 billion  share repurchase authorization (Shares in thousands) 2024 July 1,748 $ 166.33 1,748 August 6,153 165.77 6,153 September \u2014 \u2014 \u2014 Total 7,901 $ 165.90 7,901 $ 11,744 *Non-GAAP Financial Measure 2024 3Q FORM 10-Q 15 STATEMENT OF EARNINGS (LOSS) (UNAUDITED) Three Months Ended September 30 Nine months ended September 30 (In millions, per-share amounts in dollars) 2024 2023 2024 2023 Sales of equipment $ 2,448 $ 2,298 $ 7,044 $ 6,804 Sales of services 6,495 6,162 18,198 16,608 Insurance revenues (Note 12) 899 842 2,649 2,480 Total revenues 9,842 9,302 27,890 25,893 Cost of equipment sold 2,625 2,443 7,391 7,187 Cost of services sold 3,601 3,549 10,155 9,496 Selling, general and administrative expenses 1,330 1,001 3,280 2,846 Separation costs 74 147 408 474 Research and development 331 247 901 715 Interest and other financial charges 251 270 762 767 Insurance losses, annuity benefits and other costs (Note 12) 714 710 2,008 2,129 Goodwill impairments (Note 7) 251 \u2014 251 \u2014 Non-operating benefit cost (income) ( 207 ) ( 244 ) ( 628 ) ( 731 ) Total costs and expenses 8,970 8,124 24,529 22,883 Other income (loss) (Note 18) 1,021 ( 845 ) 1,965 5,755 Earnings (loss) from continuing operations before income taxes 1,893 333 5,327 8,765 Benefit (provision) for income taxes (Note 15) ( 198 ) ( 26 ) ( 567 ) ( 493 ) Earnings (loss) from continuing operations 1,695 307 4,760 8,272 Earnings (loss) from discontinued operations, net of taxes (Note 2) 147 31 ( 85 ) ( 415 ) Net earnings (loss) 1,842 338 4,676 7,857 Less net earnings (loss) attributable to noncontrolling interests ( 10 ) ( 14 ) 18 ( 37 ) Net earnings (loss) attributable to the Company 1,852 352 4,657 7,894 Preferred stock dividends \u2014 ( 91 ) \u2014 ( 295 ) Net earnings (loss) attributable to common shareholders $ 1,852 $ 261 $ 4,657 $ 7,599 Amounts attributable to common shareholders Earnings (loss) from continuing operations $ 1,695 $ 307 $ 4,760 $ 8,272 Less net earnings (loss) attributable to noncontrolling interests, continuing operations ( 10 ) 1 ( 5 ) 7 Earnings (loss) from continuing operations attributable to the Company 1,705 306 4,766 8,264 Preferred stock dividends \u2014 ( 91 ) \u2014 ( 295 ) Earnings (loss) from continuing operations attributable to common shareholders 1,705 215 4,766 7,970 Earnings (loss) from discontinued operations attributable to common shareholders 147 46 ( 108 ) ( 371 ) Net earnings (loss) attributable to common shareholders $ 1,852 $ 261 $ 4,657 $ 7,599 Earnings (loss) per share from continuing operations (Note 17) Diluted earnings (loss) per share $ 1.56 $ 0.20 $ 4.34 $ 7.25 Basic earnings (loss) per share $ 1.57 $ 0.20 $ 4.38 $ 7.32 Net earnings (loss) per share (Note 17) Diluted earnings (loss) per share $ 1.70 $ 0.24 $ 4.24 $ 6.92 Basic earnings (loss) per share $ 1.71 $ 0.24 $ 4.28 $ 6.98 2024 3Q FORM 10-Q 16 STATEMENT OF FINANCIAL POSITION (UNAUDITED) (In millions, except share amounts) September 30, 2024 December 31, 2023 Cash, cash equivalents and restricted cash $ 13,724 $ 15,204 Investment securities (Note 3) 2,232 5,706 Current receivables (Note 4) 8,936 8,703 Inventories, including deferred inventory costs (Note 5) 9,718 8,284 Current contract assets (Note 8) 2,884 2,875 All other current assets (Note 9) 1,156 1,244 Assets of businesses held for sale (Note 2) \u2014 541 Current assets 38,649 42,556 Investment securities (Note 3) 39,514 38,000 Property, plant and equipment \u2013 net (Note 6) 7,254 7,246 Goodwill (Note 7) 8,754 8,948 Other intangible assets \u2013 net (Note 7) 4,371 4,642 Contract and other deferred assets (Note 8) 4,823 4,785 All other assets (Note 9) 13,836 11,695 Deferred income taxes (Note 15) 7,491 7,502 Assets of discontinued operations (Note 2) 2,006 47,927 Total assets $ 126,698 $ 173,300 Short-term borrowings (Note 10) $ 1,681 $ 1,108 Accounts payable (Note 11) 7,829 7,516 Progress collections (Note 8) 6,477 6,177 Contract liabilities and deferred income (Note 8) 9,047 8,322 Sales discounts and allowances (Note 14) 4,073 3,741 All other current liabilities (Note 14) 4,986 4,860 Liabilities of businesses held for sale (Note 2) \u2014 378 Current liabilities 34,093 32,103 Deferred income (Note 8) 972 975 Long-term borrowings (Note 10) 18,240 19,417 Insurance liabilities and annuity benefits (Note 12) 39,147 39,624 Non-current compensation and benefits (Note 14) 7,169 7,656 All other liabilities (Note 14) 6,647 5,708 Liabilities of discontinued operations (Note 2) 1,328 39,213 Total liabilities 107,595 144,695 Common stock ( 1,082,294,004 and 1,088,415,995 shares outstanding at September 30, 2024 and December 31, 2023, respectively)  (Note 16) 15 15 Accumulated other comprehensive income (loss) \u2013 net attributable to the Company (Note 16) ( 4,375 ) ( 6,150 ) Other capital 24,406 26,962 Retained earnings 78,889 86,553 Less common stock held in treasury ( 80,061 ) ( 79,976 ) Total shareholders\u2019 equity 18,874 27,403 Noncontrolling interests 229 1,202 Total equity 19,102 28,605 Total liabilities and equity $ 126,698 $ 173,300 2024 3Q FORM 10-Q 17 STATEMENT OF CASH FLOWS (UNAUDITED) Nine months ended September 30 (In millions) 2024 2023 Net earnings (loss) $ 4,676 $ 7,857 (Earnings) loss from discontinued operations activities 85 415 Adjustments to reconcile net earnings (loss) to cash from (used for) operating activities: Depreciation and amortization of property, plant and equipment 625 592 Amortization of intangible assets (Note 7) 261 278 Goodwill impairments (Note 7) 251 \u2014 (Gains) losses on equity securities (Note 18) ( 723 ) ( 5,185 ) Principal pension plans\n metric at the company level for our performance stock units granted in 2024.",
      "score": 0.9966
    }
  ],
  "top_negative": [
    {
      "sent": "For us, particular areas where risks or uncertainties could cause our actual results to be materially different than those expressed in our forward-looking statements include: \u2022 changes in macroeconomic and market conditions and market volatility (including risks related to recession, inflation, supply chain constraints or disruptions, interest rates, values of securities and other financial assets, oil, jet fuel and other commodity prices and exchange rates), and the impact of such changes and volatility on our business operations and financial results; \u2022 global economic trends, competition and geopolitical risks, including impacts from the ongoing conflict between Russia and Ukraine and related sanctions and risks related to conflict in the Middle East; demand or supply shocks from events such as a major terrorist attack, war, natural disasters or actual or threatened public health pandemics or other emergencies; or an escalation of sanctions, tariffs or other trade tensions between the U.S.",
      "score": -0.9843
    },
    {
      "sent": "For us, particular areas where risks or uncertainties could cause our actual results to be materially different than those expressed in our forward-looking statements include: \u2022 changes in macroeconomic and market conditions and market volatility (including risks related to recession, inflation, supply chain constraints or disruptions, interest rates, values of securities and other financial assets, oil, jet fuel and other commodity prices and exchange rates), and the impact of such changes and volatility on our business operations and financial results; \u2022 global economic trends, competition and geopolitical risks, including impacts from the ongoing conflict between Russia and Ukraine and related sanctions and risks related to conflict in the Middle East; demand or supply shocks from events such as a major terrorist attack, war, natural disasters or actual or threatened public health pandemics or other emergencies; or an escalation of sanctions, tariffs or other trade tensions between the U.S.",
      "score": -0.9843
    },
    {
      "sent": "See the Non-GAAP Financial Measures secti\ntrends, competition and geopolitical risks, including impacts from the ongoing conflict between Russia and Ukraine and related sanctions and risks related to conflict in the Middle East; demand or supply shocks from events such as a major terrorist attack, war, natural disasters or actual or threatened public health pandemics or other emergencies; or an escalation of sanctions, tariffs or other trade tensions between the U.S.",
      "score": -0.9825
    }
  ],
  "forward_snippets": [
    "We continue to partner with our suppliers to improve material input, and work with our customers to calibrate future production rates.",
    "We expect the impact of supply chain constraints and inflation will continue, and we are continuing to take action to mitigate the impacts.",
    "We are monitoring the production and other challenges at The Boeing Company, including the ongoing strike, and we continue to align with them on production expectations and assess potential impacts to our business.",
    "We are in frequent communication with our airline, airframe, and maintenance, repair and overhaul (MRO) customers about the outlook for commercial air travel, new aircraft production, fleet retirements and after-market services, including shop visit and spare parts demand.",
    "We remain committed to investing in developing and maturing technologies that enable a more sustainable future of flight."
  ]
}